Responses to the survey showed that this is also the case for procurement of tissues and cells for ATMP manufacturers, in line with Article 3 of the ATMP Regulation.
Uuringu vastustest ilmnes, et kooskõlas uudsete ravimite määruse artikliga 3 kehtib see uudsete ravimite tootjate jaoks ka kudede ja rakkude hankimise puhul.